Pages that link to "Q33750337"

The following pages link to p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer (Q33750337):

Displayed 50 items.

• p53 regulation of G(2) checkpoint is retinoblastoma protein dependent (Q22254140) ‎ (← links)
• PUMA induces the rapid apoptosis of colorectal cancer cells (Q24291462) ‎ (← links)
• PUMA mediates the apoptotic response to p53 in colorectal cancer cells (Q24550772) ‎ (← links)
• Core signaling pathways in human pancreatic cancers revealed by global genomic analyses (Q24606006) ‎ (← links)
• Dietary flavonoids and the MLL gene: A pathway to infant leukemia? (Q24609631) ‎ (← links)
• Surfing the p53 network (Q28032484) ‎ (← links)
• Analysis of epidemiological cohort data on smoking effects and lung cancer with a multi-stage cancer model (Q31029639) ‎ (← links)
• Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes (Q33335165) ‎ (← links)
• Clinical outcomes and correlates of TP53 mutations and cancer (Q33693838) ‎ (← links)
• Expression and prognostic significance of Cox-2 and p-53 in Hodgkin lymphomas: a retrospective study (Q33784787) ‎ (← links)
• TP53 mutations in Korean patients with non-small cell lung cancer (Q33807219) ‎ (← links)
• Role of p53 serine 46 in p53 target gene regulation (Q33843352) ‎ (← links)
• Carcinogenesis in mouse and human cells: parallels and paradoxes (Q33846175) ‎ (← links)
• Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk (Q33905119) ‎ (← links)
• Calcium, vitamin D, VDR genotypes, and epigenetic and genetic changes in rectal tumors (Q33954687) ‎ (← links)
• Alcohol consumption and rectal tumor mutations and epigenetic changes (Q34007796) ‎ (← links)
• Reduced rates of gene loss, gene silencing, and gene mutation in Dnmt1-deficient embryonic stem cells. (Q34012712) ‎ (← links)
• Mechanisms of cell-cycle checkpoints: at the crossroads of carcinogenesis and drug discovery (Q34119143) ‎ (← links)
• Polymorphisms of TP53 Arg72Pro, but not p73 G4C14>A4TA4 and p21 Ser31Arg, contribute to risk of cutaneous melanoma (Q34121882) ‎ (← links)
• Mutational spectral analysis at the HPRT locus in healthy children (Q34144257) ‎ (← links)
• Identification of a new tumor suppressor gene located at chromosome 8p21.3–22 (Q34190202) ‎ (← links)
• Human germline mutation in the factor IX gene (Q34397965) ‎ (← links)
• TP53: a key gene in human cancer. (Q34568607) ‎ (← links)
• p53 as a mutagen test in breast cancer (Q34580735) ‎ (← links)
• Household income is associated with the p53 mutation frequency in human breast tumors (Q34613059) ‎ (← links)
• Likelihood Models of Somatic Mutation and Codon Substitution in Cancer Genes (Q34618683) ‎ (← links)
• Significance of TP53 mutations in human cancer: a critical analysis of mutations at CpG dinucleotides (Q35078721) ‎ (← links)
• Aberrant ubiquitin-mediated proteolysis of cell cycle regulatory proteins and oncogenesis (Q35094511) ‎ (← links)
• Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer (Q35190796) ‎ (← links)
• Evidence for activation of mutated p53 by apigenin in human pancreatic cancer (Q35751608) ‎ (← links)
• Down-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathways by p53 in squamous cell carcinoma (Q35791826) ‎ (← links)
• Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns (Q36253611) ‎ (← links)
• Methylation of cytosine at C5 in a CpG sequence context causes a conformational switch of a benzo[a]pyrene diol epoxide-N2-guanine adduct in DNA from a minor groove alignment to intercalation with base displacement (Q36412573) ‎ (← links)
• Study of p53 gene alteration as a biomarker to evaluate the malignant risk of Lugol-unstained lesion with non-dysplasia in the oesophagus (Q36609832) ‎ (← links)
• NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2. (Q36636154) ‎ (← links)
• Pathological features and genetic alterations in colorectal carcinomas with characteristics of nonpolypoid growth (Q36695306) ‎ (← links)
• p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation. (Q37010494) ‎ (← links)
• Cytosine methylation effects on the repair of O6-methylguanines within CG dinucleotides. (Q37371614) ‎ (← links)
• Tumor markers and rectal cancer: support for an inflammation-related pathway (Q37401248) ‎ (← links)
• Is there a specific mutation of p53 gene due to radon exposure? A systematic review (Q37500150) ‎ (← links)
• APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase (Q37577458) ‎ (← links)
• Mapping structurally defined guanine oxidation products along DNA duplexes: influence of local sequence context and endogenous cytosine methylation (Q37701731) ‎ (← links)
• Distinct roles of Kaposi's sarcoma-associated herpesvirus-encoded viral interferon regulatory factors in inflammatory response and cancer (Q38115771) ‎ (← links)
• Specific interaction of p53 with target binding sites is determined by DNA conformation and is regulated by the C-terminal domain (Q38363728) ‎ (← links)
• Chromosomal numerical abnormalities in early stage lung adenocarcinoma (Q38438727) ‎ (← links)
• Molecular fingerprints of environmental carcinogens in human cancer. (Q38507277) ‎ (← links)
• Identification of a novel feline large granular lymphoma cell line (S87) as non-MHC-restricted cytotoxic T-cell line and assessment of its genetic instability (Q38756864) ‎ (← links)
• The NAD(+) salvage pathway modulates cancer cell viability via p73. (Q38818192) ‎ (← links)
• Clinical Outcomes of TP53 Mutations in Cancers (Q38906201) ‎ (← links)
• The role of p300 in the tumor progression of oral squamous cell carcinoma (Q38963086) ‎ (← links)